<?xml version="1.0" encoding="UTF-8" ?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">


<journal>
<language>en</language>
<journal_id_issn>1726-7536</journal_id_issn>
<journal_id_issn_online>1735-8507</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi></journal_id_doi>
<journal_id_isnet></journal_id_isnet>
<journal_id_iranmedex>69</journal_id_iranmedex>
<journal_id_magiran>2139</journal_id_magiran>
<journal_id_sid>288</journal_id_sid>
<pubdate PubStatus="epublish">
	<type>gregorian</type>
	<year>2017</year>
	<month>10</month>
	<day>4</day>
</pubdate>
<volume>18</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>29201668</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Efficacy of Intrauterine Injection of Granulocyte Colony Stimulating Factor (G-CSF) on Treatment of Unexplained Recurrent Miscarriage: A Pilot RCT Study</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;Background: Endometrium undergoes several changes in structure and cellular composition during pregnancy. Granulocyte Colony-stimulating Factor (GCS-F) is an important cytokine with critical role in embryo implantation and pregnancy. The aim of the present study was to evaluate the impact of intrauterine injection of G-CSF in patients who suffer from unexplained recurrent miscarriage (RM).&lt;br /&gt;
Methods: In the present randomized clinical trial, a total of 68 patients were randomly allocated into two study groups including intrauterine G-CSF (n=23, 300 &lt;em&gt;&amp;mu;g&lt;/em&gt;) injection and control group (n=27, no G-CSF injection). Eighteen out of 68 patients were excluded from the final analysis due to different reasons. All patients were in Ovulation Induction (I/O) cycle. In G-CSF group, intrauterine injection of G-CSF was done twice in the cycle. All enrolled patients were under 40 years old and had at least two unexplained pregnancy losses. Pregnancy was evaluated by titer of &amp;beta;hCG, presence of gestational sac (implantation) and fetal heart rate (clinical pregnancy) was assessed by vaginal ultrasonography. Student&amp;rsquo;s T test and Mann-Whitney U were used for analysis. The p&amp;le;0.05 was determined as statistically significant.&lt;br /&gt;
Results: No significant differences were observed between the two study groups when the rates of chemical pregnancy (26.1%&lt;em&gt; vs.&lt;/em&gt; 29.6%, p=0.781), implantation (26.1% &lt;em&gt;vs.&lt;/em&gt; 22.2%, p=0.750), clinical pregnancy (17.4% &lt;em&gt;vs.&lt;/em&gt; 11.1%, p=0.689) and abortion (33% &lt;em&gt;vs.&lt;/em&gt; 37.5%, p=0.296) were compared.&lt;br /&gt;
Conclusion: In our study, no significant difference was observed between the two study groups when the rates of chemical pregnancy, implantation, clinical pregnancy and abortion were compared.&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Granulocyte colony-stimulating factor, Intrauterine injection, Recurrent miscarriage</keyword>
	<start_page>379</start_page>
	<end_page>386</end_page>
	<web_url>https://www.jri.ir/article/721</web_url>
	<pdf_url>https://www.jri.ir/documents/fullpaper/en/721.pdf</pdf_url>
	<author_list><author><first_name>Simin</first_name><middle_name></middle_name><last_name>Zafardoust</last_name><suffix></suffix><affiliation>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>1405</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mohammad Mehdi</first_name><middle_name></middle_name><last_name>Akhondi</last_name><suffix></suffix><affiliation>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation><first_name_fa>محمدمهدی</first_name_fa><middle_name_fa></middle_name_fa><last_name_fa>آخوندی</last_name_fa><suffix_fa></suffix_fa><email></email><code>21</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mohammad Reza</first_name><middle_name></middle_name><last_name>Sadeghi</last_name><suffix></suffix><affiliation>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation><first_name_fa> محمدرضا</first_name_fa><middle_name_fa></middle_name_fa><last_name_fa>صادقی</last_name_fa><suffix_fa></suffix_fa><email></email><code>77</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Afsaneh</first_name><middle_name></middle_name><last_name>Mohammadzadeh</last_name><suffix></suffix><affiliation>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation><first_name_fa>افسانه</first_name_fa><middle_name_fa></middle_name_fa><last_name_fa>محمدزاده</last_name_fa><suffix_fa></suffix_fa><email></email><code>684</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Atousa</first_name><middle_name></middle_name><last_name>Karimi</last_name><suffix></suffix><affiliation>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>1760</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Sheyda</first_name><middle_name></middle_name><last_name>Jouhari</last_name><suffix></suffix><affiliation>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>1761</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Soheila</first_name><middle_name></middle_name><last_name>Ansaripour</last_name><suffix></suffix><affiliation>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email>soh.ansaripour@gmail. com</email><code>1762</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

</articleset>
</journal>

